Dynatronics Corp (DYNT): Kapitalisasi marang pendapatan

Simbol lan logo merek Dynatronics Corp. (DYNT)

Growth for Dynatronics Corporation (DYNT) is being constrained by reductions in government clinic budgets and fierce competition within the rehabilitation niche. The historical P/S ratio confirms valuation volatility, with the most recent value recorded as 0.00. Stability is supported by the implementation of energy-efficient production cycles and eco-friendly packaging; however, the complete abandonment of in-house R&D in favor of distribution nullifies the company's technological potential.

DYNT Multiplikator P/S Dynatronics Corp. (04.07.2022 - 04.08.2024)

Rincian analitis perusahaan Dynatronics Corporation (DYNT)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:DYNT Dynatronics Corp
Barang utama Dynatronics

The P/S ratio determines the market value of one dollar of revenue, allowing an investor to assess the extent of overpayment for a business relative to its sales volumes. When analyzing the market capitalization-to-revenue ratio of Dynatronics Corporation (DYNT), one must consider the company's limited pricing power in the rehabilitation sector, which makes this metric a key indicator of business resilience amid fierce competition and low margins.

Pesaing Dynatronics Corporation

BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical International - Kapitalisasi marang volume dodolan|VANI: Multiplikator P/S|Rasio kapitalisasi marang pendapatan XTNT|Kapitalisasi marang pendapatan NMTC|Rega marang dodolan Modular Med MODD|Rasio rega marang pendapatan Myomo, Inc (MYO)|Envoy Medical Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S VVOS (Vivos Therapeutics)|Multiplikator P/S envveno.com NVNO|SINT: Kapitalisasi marang pendapatan|Tenon Medical Inc. - Kapitalisasi marang volume dodolan|ReWalk Robotics Ltd (LFWD) - Rasio rega marang pendapatan|Autonomix Medical - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan INVO Fertility Inc|Rega marang dodolan bonebiologics.com BBLG|Rasio rega marang pendapatan Axonics (AXNX)|BIOLASE Inc. - Rasio kapitalisasi marang pendapatan|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)